Wordt geladen...
Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability
The cannabinoid 1 (CB(1)) receptor antagonist rimonabant (SR141716) alters rewarding properties and intake of food and drugs. Additionally, striatal dopamine D2 receptor (DRD2) availability has been implicated in reward function. This study shows that chronic treatment of rats with rimonabant (1.0 a...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3252421/ https://ncbi.nlm.nih.gov/pubmed/21955259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1369-1600.2011.00369.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|